Project Grant K23MH144215
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $854,029 Project Grant on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a multimodality adaptive intervention for reducing suicide risk in the critical three-month period following inpatient psychiatric hospitalization. The grant supports a five-year research initiative (through August 31, 2030) employing a hybrid...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a five-year Mentored Research Scientist Development Award totaling $182,851 under the Mental Health Research Grants program (CFDA 93.242), effective September 19, 2025, through August 31, 2030. This project grant supports research to identify deficient memory replay as a potentially treatable mechanism underlying impaired sleep-dependent memory consolidation (SDMC) in schizophrenia...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $183,118 on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242). Under the direction of Dr. Tubbs, this research initiative will deliver integrated genomic and electronic health record (EHR) analyses designed to advance precision psychiatry by addressing critical gaps in translating genetic findings to clinical practice. The...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $790,560 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective April 1, 2026 through March 31, 2030. The award funds research to develop advanced artificial intelligence (AI) models for predicting differential antidepressant treatment responses by integrating electronic health record (EHR) data with genomic information. The research addresses...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded McLean Hospital Corporation a $193,320 Project Grant under the Mental Health Research Grants program (CFDA 93.242) on February 18, 2026, with a completion date of January 31, 2031. This K23 mentored research award funds a study investigating online social networking (OSN) mechanisms of suicide risk in adolescents ages 13-17. The research will collect multimodal data—including active OSN metrics (texting and...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $197,614 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective April 1, 2026 through March 31, 2031. This K23 Mentored Patient-Oriented Research Career Development Award supports the development of electroencephalographic (EEG)-based digital biomarkers for the detection and monitoring of catatonia, a potentially fatal but treatable neuropsychiatric...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $185,552 Project Grant effective September 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate neurocognitive responses to social threat and their connection to suicidality in adolescent girls. The research will generate scientific knowledge through a K23 mentored research career development award examining how sustained neural responsivity to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (through its New York State Psychiatric Institute division) under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2025, for a five-year project period extending through July 31, 2030. This Project Grant funds a clinical research study examining the role of the anterior hippocampus in major depressive disorder (MDD) pathogenesis....
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Stanford University a $116,837 project grant under the Mental Health Research Grants program (CFDA 93.242) beginning May 4, 2026, with completion targeted for April 30, 2028. The grant supports research investigating sleep-based theta burst stimulation as an enhanced neuromodulation approach for treating depression. The primary deliverables include development and testing of automated systems for real-time...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $820,196 Project Grant award from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), effective March 5, 2026, through February 28, 2031. The research project, "Impact of Circadian Misalignment for Adolescents with ADHD: Observational and Mechanistic Data," will generate observational and mechanistic research findings examining the relationship...
The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $197,578 Project Grant (K23 award) effective June 1, 2026 through May 31, 2031 under the Mental Health Research Grants program (CFDA 93.242). This intensive longitudinal research study investigates sleep and circadian rhythm irregularities as short-term risk factors for adolescent suicide. The research will recruit 100 hospitalized adolescents with suicidal thoughts and behaviors, utilizing objective measurement technologies including wrist actigraphy to monitor sleep metrics and continuous urine sampling to assess circadian timing via 6-sulfatoxymelatonin (AMT6s). Participants will complete ecological momentary assessments of suicidal ideation during hospitalization and at 1 and 3 months post-discharge, a critical period of heightened suicide risk. The study will produce empirical evidence on whether night-to-night sleep variations predict next-day suicidal ideation during hospitalization and subsequent suicidal thoughts and behaviors after discharge, and whether later circadian timing is associated with elevated suicide risk. This research addresses documented gaps in understanding dynamic, short-term mechanisms linking sleep and circadian system changes—which undergo marked shifts during adolescence—to suicide risk, moving beyond reliance on retrospective self-report and static risk factors. Expected research products include peer-reviewed publications, mechanistic insights into the relationship between sleep irregularities and suicide risk in adolescents, and potential identification of modifiable targets for suicide prevention interventions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $197.6k | 6/5/26 |